Drug General Information |
Drug ID |
D02NNS
|
Former ID |
DNC003765
|
Drug Name |
SNAP-8719
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C22H28F3N3O2
|
Canonical SMILES |
CC(CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O
|
InChI |
1S/C22H28F3N3O2/c1-15(28-20(29)12-22(13-21(28)30)4-2-3-5-22)14-26-6-8-27(9-7-26)19-11-17(24)16(23)10-18(19)25/h10-11,15H,2-9,12-14H2,1H3/t15-/m1/s1
|
InChIKey |
WCWNYVYNQAPOOX-OAHLLOKOSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
5-hydroxytryptamine 1A receptor |
Target Info |
Inhibitor |
[1]
|
Alpha-1A adrenergic receptor |
Target Info |
Inhibitor |
[1]
|
Alpha-1D adrenergic receptor |
Target Info |
Inhibitor |
[1]
|
Alpha-1B adrenergic receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
cAMP signaling pathway
|
Neuroactive ligand-receptor interaction
|
Serotonergic synapsehsa04020:Calcium signaling pathway
|
cGMP-PKG signaling pathway
|
AMPK signaling pathway
|
Adrenergic signaling in cardiomyocytes
|
Vascular smooth muscle contraction
|
Salivary secretionhsa04020:Calcium signaling pathway
|
Salivary secretion
|
NetPath Pathway
|
IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
5HT1 type receptor mediated signaling pathwayP00002:Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
|
Pathway Interaction Database
|
LPA receptor mediated events
|
Reactome
|
Serotonin receptors
|
G alpha (i) signalling eventsR-HSA-390696:Adrenoceptors
|
G alpha (q) signalling events
|
G alpha (12/13) signalling eventsR-HSA-390696:Adrenoceptors
|
G alpha (12/13) signalling events
|
WikiPathways
|
Serotonin HTR1 Group and FOS Pathway
|
SIDS Susceptibility Pathways
|
Monoamine GPCRs
|
GPCRs, Class A Rhodopsin-like
|
GPCR ligand binding
|
GPCR downstream signalingWP58:Monoamine GPCRs
|
Calcium Regulation in the Cardiac Cell
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
Endothelin Pathways
|
GPCR downstream signaling
|
AMPK SignalingWP58:Monoamine GPCRs
|
GPCRs, OtherWP58:Monoamine GPCRs
|
Vitamin D Receptor Pathway
|
AMPK Signaling
|
References |
REF 1 | J Med Chem. 2005 Apr 21;48(8):3076-9.Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists. |